✦ LIBER ✦

High-Dose Donepezil (23 mg/day) for the Treatment of Moderate and Severe Alzheimer's Disease: Drug Profile and Clinical Guidelines

✍ Scribed by Cummings, Jeffrey L.; Geldmacher, David; Farlow, Martin; Sabbagh, Marwan; Christensen, Daniel; Betz, Peter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subgroup Analysis of US and Non-US Patie

✍ Salloway, S.; Mintzer, J.; Cummings, J. L.; Geldmacher, D.; Sun, Y.; Yardley, J. 📂 Article 📅 2012 🏛 SAGE Publications 🌐 English ⚖ 534 KB

Effectiveness and tolerability of high-d

✍ Martin R. Farlow; Stephen Salloway; Pierre N. Tariot; Jane Yardley; Margaret L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Evaluating the cognitive effects of done

✍ Marwan Sabbagh, Jeffrey Cummings, Daniel Christensen, Rachelle Doody… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 347 KB

Efficacy and Safety of Donepezil 23 mg v

✍ Doody, Rachelle S.; Geldmacher, David S.; Farlow, Martin R.; Sun, Yijun; Moline, 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 458 KB

Use of donepezil for the treatment of mi

✍ Ian Cameron; Stephen Curran; Paul Newton; Duncan Petty; John Wattis 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

Commentary on “Health economics and the

✍ Roy Jones 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 110 KB